Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.44 HKD | -1.33% | -5.93% | -1.11% |
May. 31 | Genertec Universal Medical Unit to Raise 1 Billion Yuan from Corporate Bond Issue | MT |
May. 16 | Genertec Universal Medical Group Company Limited Announces Director and Committee Changes | CI |
Strengths
- The group's high margin levels account for strong profits.
- Its low valuation, with P/E ratio at 4.18 and 3.83 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Corporate Financial Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.11% | 1.07B | - | ||
+81.72% | 8.45B | D | ||
-2.85% | 5.15B | C | ||
-5.01% | 4.52B | C+ | ||
+18.33% | 3.79B | - | - | |
+59.71% | 3.59B | - | C+ | |
+1.43% | 2.38B | - | ||
+9.81% | 1.64B | - | C- | |
+4.05% | 1.21B | - | ||
-13.77% | 1.08B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 2666 Stock
- Ratings Genertec Universal Medical Group Company Limited